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SUPPLEMENTING DSHEA ONE STEP AT A TIME:
THE FDA'S MODERNIZATION PLAN

I.

INTRODUCTION

Dietary supplements are a multibillion-dollar industry.1 With
roughly 80,000 products being marketed to consumers, 2 instead of eating a well-balanced diet, individuals can choose to get "health benefits" from teas, gummies, pills, drink mixes, protein powders, and even
candy.3 Most legislation regulating these products focuses on consumer access, and therefore has severely limited the Food & Drug Administration (FDA)'s ability to protect society from "bad actors"
looking to profit from this growing market. 4 To combat such limitations, the FDA has developed a five-step plan to modernize the most
"current" supplement regulations, while maintaining a better balance
between consumer access and safety.5 This Comment will critique this
modernization plan and offer additional recommendations to ensure
both product safety and consumer access.
Part II will provide background on how the government defines a
dietary supplement and the current usage trends and consumer ideologies towards these types of products in the United States. Furthermore, Part II provides a background of past and current legislation
governing the supplement industry, changes made to each legislation,
and why such changes took place. Finally, Part II will lay out each of
the five steps the FDA plans to implement to modernize the Dietary
1. Dietary Supplements Market Analysis, By Ingredient (Botanicals, Vitamins, Others) By
Product (Tablets, Capsules, Others), By Application (Medicinal, Sports, Others), By Distribution
Channel (Online, Pharmacies, Others), Forecasts To 2027, REPORTS & DATA (Aug. 2020), https:/
/www.reportsanddata.com/report-detail/dietary-supplements-market.
2. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency's new efforts to

strengthen regulation of dietary supplements by modernizing and reforming FDA's oversight, U.S.
FOOD & DRUG ADMIN. (Feb. 11, 2019), https://www.fda.gov/news-events/press-announcements/
statement-fda-commissioner-scott-gottlieb-md-agencys-new-efforts-strengthen-reguationdietary.
3. Most drugs stores offer supplements in a variety of different forms for all age groups. See,
e.g., wALMART.COM, https://www.walmart.com/search/?query=dietary%20supplements&type
ahead=dietary (last visited Aug. 30, 2020).
4. Laurie McGinley, FDA launches tougher oversight of supplements, wAsh. POsT (Feb. 11,
2019, 10:02 AM), https://www.washingtonpost.com/health/2019/02/11/fda-launches-tougher-over
sight-supplements/.
5. U.S. FOOD AND DRUG ADMINISTRATION, supra note 2.
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Supplement Health and Education Act (DSHEA), the current governing legislation.
Part III of this Comment discusses the main regulation and policy

gaps created by the DSHEA. Part III analyzes which of the FDA's
modernization plan steps work towards filling the regulation and policy gaps and the likelihood that the steps will be successful. Lastly,
Part III describes the overall powers and authorities the FDA has to
regulate dietary supplements.
Part IV of this Comment suggests that while the FDA's modernization plan is an important first step, it will likely not be successful as it
is too general and involves actions the FDA has already implemented
in the past. Part IV further recommends that the FDA should require
minimum age recommendations on product labels, implement ran-

domized ingredient checks, conduct additional unbiased research, and
increase warning labels. Part IV concludes that these specific steps will
likely increase public safety and provide safeguards than the pro-industry legislation currently in place.

II.

BACKGROUND

While the first dietary supplements were marketed in the early
nineteenth century, 6 the belief that certain foods and their ingredients
could relieve symptoms of, and even cure, various diseases developed
long before.7 Soon after the discovery of dietary supplements, food
manufacturers were able to transform these isolated chemicals into
marketable products. By the end of the Second World War, consumers
were offered vitamins "in forms never before seen in nature-vitamin-fortified peanut butter, vitamin gum, even vitamin doughnuts." 8
Despite the lack of scientific and medical research supporting these
new products, the general public accepted them as inherently good
and the dietary supplement industry began to "take on a life of [its]

own." 9
6. Richard D. Semba, The Discovery of the Vitamins, 82 INT'I. J. FOR VITAMIN & NUTRITION
Res. 310, 310-11 (2012).
7. Many ancient remedies involved ingesting plants, herbs, and other natural chemicals that
fall under the dietary supplement definition. See 11 Ancient Remedies that Effectively Treat Modern Ailments, ANCIENT ORIGINS (July 6, 2019, 11:05 PM), https://www.ancient-origins.net/history
/ancient-remedies-0012251; Native American Remedies, NATIVE NET, https://www.native-net.org/
na/native-american-remedies.html (last visited Nov. 3, 2020).
8. CATIIERINE PRICE, VITAMANIA: OUR OnSESSIVIi QUEST FOR NUTRITIONAL. PERFHCTION XI

(2015).
9. Id.
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What is a Dietary Supplement?

The Dietary Supplement Health and Education Act of 1994
(DSHEA) defines a dietary supplement as "a product (other than tobacco) that (1) is intended for ingestion, taken by mouth in pill, capsule, tablet or liquid form; (2) contains at least one dietary ingredient
including vitamins, minerals, herbs or other botanicals, amino acids,
and other substances; (3) is intended to supplement the diet by increasing total dietary intake; and (4) is labeled as such." 10 Generally, a
product is categorized as a dietary supplement based on the information provided by the manufacturer on either the product's label or
additional literature.1 1 Since dietary supplements contain dietary ingredients and are intended to supplement one's diet, they fall within
the "food category" for regulation under the FDA.12 However, they
are not regulated using the same standard as "conventional foods." 1 3
Like other types of food and drugs, supplements must meet label
requirements set by the FDA. 14 However, unlike drugs, supplement
labels cannot legally contain claims that the "product will diagnose,
cure, mitigate, treat, or prevent a disease." 1 5 Supplement labels can
contain health claims, nutrient content claims, or structure/function
claims.1 6 A health claim describes the correlation between the product
and a risk reduction in a disease or condition.17 A nutrient claim describes the amount of each supplement within the product. 18 A structure/function claim describes the product's effect on the body's
function without specifying any disease.1 9 While these claims do require a disclaimer, and a manufacturer making such claims must notify
10. Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 Stat. 427
(1994) (codified as amended at 21 U.S.C. § 321(ff)(1)(A)-(E) (2016)).
11. Dietary Supplements, OFF. DIETARY SUPPLEMENTS, NAT'L INSTs. HEALTH, https://
ods.od.nih.gov/factsheets/DietarySupplements-Consumer (last updated Mar. 11, 2020).
12. Id.
13. Questions and Answers on Dietary Supplements, U.S. FOOD & DRUG ADMIN., https://
www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-di
etary-supplements (last updated July 22, 2019).
14. Dietary Supplement Labeling Guide, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/
food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplement-labeling-guide (last updated Sept. 20, 2018).
15. 21 U.S.C. § 343(r)(6)(C) (2010); OFFICE OF DIETARY SUPPLEMENTS, supra note 11.
16. 21 U.S.C. § 343(r)(6)(A); OFFICE OF DIETARY SUPPLEMENTS, supra note 11.
17. Label Claims for Conventional Foods and Dietary Supplements, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/food/food-labeling-nutrition/label-claims-conventional-foods-and-dietary-supplements (last updated June 19, 2018).
18. 21 U.S.C. § 343(r)(1)(A).
19. Id. § 343(r)(6)(A).
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the FDA and be able to substantiate the claims, 20 structure/function
claims are not subject to FDA approval. 2 1
B.

Current Use and Ideology

In 2019, the global dietary supplement industry was valued at $147.8

billion and is expected to exceed $228.19 billion by 2027.22 According
to a 2019 consumer report, in the United States alone 77% of all
adults-70% of those between eighteen and thirty-four years old,
81% of those between thirty-five and fifty-four years old, and 79% of
those who are age fifty-five and older-take at least one dietary supplement. 23 This is a drastic increase from the estimated 42% of adults
taking supplements from 1988 to 1994 and the 53% of adults taking

supplements from 2003 to 2006.24
Similarly, the number of supplements marketed to the public has
also skyrocketed. In 1994, the dietary supplement industry consisted
of about 4,000 products. 25 Now, the industry offers more than 80,000
products to consumers. 2 6 This is partly due to supplement manufacturers and advertisers using and abusing terms the public generally associates with their health, such as "vitamins." 2 7 When vitamins were first
discovered, they were used to cure and prevent terrible diseases that
were rampant throughout the world. 2 8 For example, vitamin C was
used to cure scurvy; vitamin D cured rickets; vitamin B1 was used to
treat beriberi; and vitamin B3 was used to treat pellagra. 29 While these
diseases have virtually been eradicated in most developed countries, 30
the idea that vitamins contain miraculous healing powers remains.
This idea, coupled with the assumption that because dietary supplements are not considered "drugs," they are risk-free, has created a
supplement-obsessed society that believes anything the companies
profiting from these products tell them. 31 Despite their overwhelming
20. Id. § 343(r)(6)(B).
21. Id. § 343(r)(6)(A);

OFFICE OK

DIETARY SUPPLEMENTS,

supra note 11.

22. REPORTS AND DATA, supra note 1.
23. Dietary Supplement Use Reaches All Time High, COUNCIL FOR RESPONSIBLE NUTRITION,

https://www.crnusa.org/CRNConsumerSurvey

(last visited Aug. 30, 2020).

24. Brandon Gaille, 20 Dietary Supplement Industry Statistics, BRANDONGAILIE.COM (Oct.

12, 2013), https://brandongaille.com/20-dietary-supplement-industry-statistics.
25. U.S. FooD AND DRUG ADMINISTRATION, supra note 2.
26. Id.
27. PRICE, supra note 8, at xii.
28. Id. at xi.
29. Dina Khairie, Vitamin Deficiency - Four Common Diseases Caused by Vitamin Deficiency, NOOR VITAMINS, https://www.noorvitamins.com/Health-Blog/vitamin-deficiency-diseases
(last visited Aug. 30, 2020).
30. PRIci, supra note 8, at xii.
31. Id.
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prevalence in society, economic impact, and a lack of scientific research concerning their risks and benefits, dietary supplements have
historically been subject to very little government regulation. 32
C.

1.

Past and Current Regulation

The Wiley Act

The first comprehensive federal law that regulated food and drug
products, including substances now considered to be dietary supplements, was the Food and Drugs Act of 1906, more commonly known
as the "Wiley Act." 3 3 The Wiley Act was passed in response to the
public's demand for protection against the deceptive practices of the
food and drug industry. 34 This demand was further fueled by journalists exposing the hazardous conditions of the marketplace. 35 It was the
vile condition of the meat-packing industry that was the final motivator behind the creation of a comprehensive food and drug law. 36
Thus, the Wiley Act's purpose was to prevent "the manufacture, sale
or transportation of" food or drugs that were adulterated or mislabeled in such a way that would either dangerously lower the product's
standard of quality or deceive the consumer about the product's
quality. 37
Under the Wiley Act, the Department of Agriculture could seize
questionable products, collect product samples, conduct examinations
of such samples, and initiate court proceedings against those who violated the Act.38 The basis of the Wiley Act and its enforcement focused on product labeling rather than pre-market approval, so while
ingredients were tested to ensure consumer safety, any claims about
the products were not. 39 While this law was considered the "pinnacle
of Progressive Era legislation" at the time, both a lack of research and
manufacturers' ability to easily work around the Act's regulations
32. See infra Part I.C.
33. How did the Federal Food, Drug, and Cosmetic Act come about?, U.S. FOOD & DRUG
ADMIN., https://www.fda.gov/about-fda/fda-basics/how-did-federal-food-drug-and-cosmetic-actcome-about (last updated Mar. 28, 2018).
34. Pure Food and Drugs Act, § 1, 59 Pub. L. No. 384, 34 Stat. 768 (1906).
35. Part I: The 1906 Food and Drugs Act and Its Enforcement, U.S. FOOD & DRUG ADMIN.,
https://www.fda.gov/about-fda/fdas-evolving-regulatory-powers/part-i-1906-food-and-drugs-actand-its-enforcement (last updated Apr. 24, 2019).
36. Id.
37. See generally Pure Food and Drugs Act.
38. Id. § 3-5.
39. See generally Pure Food and Drugs Act; see also U.S. FOOD AND DRUG ADMINISTRATION,
supra note 2.
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heightened the pressure for more legislation as general use of supplements increased during World War II.40
2.

Food, Drug, and Cosmetic Act of 1938

With the election of President Franklin D. Roosevelt and the beginning of the new progressive movement, consumer protection and regulation became the objective of many newly established government
agencies, such as the FDA. 41 Surprisingly, the proposed Food, Drug,
and Cosmetic Act, which would ultimately replace the Wiley Act, was
not widely known by the general public. 42 Due to the lack of both
public support and knowledge, Congress was reluctant to sponsor the
bill for over five years. 43 Public support for new food and drug legislation did not develop until a new wave of journalists and consumer
protection organizations demonstrated the ineffectiveness of the Wiley Act.44 Among these organizations was the FDA, which assembled
a list of products that were legal under the existing Wiley Act, but
posed extreme risks to the health of consumers. 4 5 Unfortunately,
stronger restrictions were not implemented on the food and drug industries until many years later, after a new drug product claimed the
lives of many children.
In 1937, a Tennessee pharmaceutical company began marketing and
distributing a new drug for children known as "Elixir Sulfanilamide." 46 Because "[t]he existing Food and Drugs Act [did] not require
that new drugs be tested before they are placed on sale[,]" the drug
was "tested by the firm for flavor but not for its effect on human
life." 4 7 As a result, nearly one hundred people across fifteen states
died, many of which were children. 48 The public outcry against the
40. U.S. FOOD AND DRUGC ADMINISTRATION, supra note 33.
41. Part II: 1938, Food, Drug, Cosmetic Act, U.S. FOOD & DRUG ADMIN., https://
www.fda.gov/about-fda/fdas-evolving-regulatory-powers/part-ii-1938-food-drug-cosmetic-act
(last updated Nov. 27, 2018).
42. David F. Cavers, The Food, Drug, and Cosmetic Act of 1938: Its Legislative History and Its
Substantive Provisions, 6 L. & CONTiMP. PROns. 2, 3 (1939).
43. Id. at 2-3.
44. U.S. FOOD AND DReuO ADMINISTRATION, supra note 41.
45. See id. ("It included Banbar, a worthless 'cure' for diabetes that the old law protected;
Lash-Lure, an eyelash dye in which a number of women suffered injuries to their eyes, including
one confirmed case of permanent blindness.; numerous examples of foods deceptively packaged
or labeled; Radithor, a radium-containing tonic that sentenced users to a slow and painful death;
and the Wilhide Exhaler, which falsely promised to cure tuberculosis and other pulmonary
diseases.").
46. H.A. wALLACE, LEVIER FROM TIlE SECRETARY OP AGRICUILIURE, S. Doc. No. 124, at I
(2d Sess., 1937).
47. Id.
48. U.S. FOOD AND DRUG ADMINISTRATION, supra note

41.
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existing food and drug regulations, especially in support of the prevention of similar tragedies propelled the Food, Drug, and Cosmetic Act
through Congress, which was signed into effect by President
Roosevelt on June 25, 1938.4
The new legislation enhanced the federal government's control of
the food and drug industry by bringing it under the regulatory powers
of the FDA. 50 It also required pre-market approval of any new drug,
meaning the manufacturer had to prove the safety of the drug to the
FDA.51 Among other things, the Act prohibited manufacturers from
using false claims on labels; provided food standards to ensure correct
packaging and food quality; included the regulation of cosmetics and
medical devices; required product labels to include directions for safe
use; and allowed for factory inspections.5 2 Most importantly, the Act
provided for the regulation of "food for special dietary uses," by stat-

ing that food is misbranded:
If it purports to be or is represented for special dietary uses, unless
its label bears such information concerning its vitamin, mineral, and
other dietary properties as the Secretary determines to be, and by
regulations prescribes as, necessary in order fully to inform purchasers as to its value for such uses.53

In 1941, the FDA began promulgating regulations under Section
343(j) of the Food, Drug, and Cosmetic Act, defining the term "food
for special dietary uses" as "[u]ses for supplementing or fortifying the
ordinary or usual diet with any vitamin, mineral or other dietary property. Any such particular use of a food is a special dietary use, regardless of whether such food also purports to be or is represented for
general use." 54 The regulation also allowed the FDA to bring misbranded drug actions against manufacturers that included disease-related labeling claims on special dietary use products.55 For example, in
United States v. Kordel, the defendant, a distributor of healthy beverages and mineral tablets, was convicted of distributing misbranded
drugs into interstate commerce. 56 The Seventh Circuit held the literature shipped with these products constituted labeling under the Food,
49. Id.
50. Federal Food, Drug, and Cosmetic Act, Pub. L. No. 75-717, 52 Stat. 1040 (1938) (codified
at 21 U.S.C. §§ 321-99(i)).
51. Id. § 201. At this time, supplements were still considered to be both food and drugs, depending on the product's claims.
52. See generally 21 U.S.C. §§ 321-99(i).
53. Id. § 343(j) (2010).
54. Regulations for the Enforcement of the Federal Food, Drug, and Cosmetic Act, 6 Fed.
Reg. 5,909, 5,921 (Nov. 22, 1941).
55. Id.
56. 164 F.2d 913, 917 (7th Cir. 1947).
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Drug, and Cosmetic Act, and therefore was subject to misbranding

liability if they included disease-related claims.5 7
The Food, Drug, and Cosmetic Act also governed the labeling of
vitamins and established a Minimum Daily Requirement (MDR) for

each vitamin. 58 However, it did not provide a maximum amount of
vitamins allowed in supplements. 59 This proved to be a dangerous
mistake as those who profited from supplements made claims that
mega-doses of such supplements were not only risk-free, but even
more effective than the recommended daily amount. 60 While the FDA
recognized the seriousness of these claims, it was only able to control
such occurrences on a case-by-case basis. Given the rate of industry
growth, this cost the agency substantial amounts of time and money. 61
Thus, the FDA quickly realized that stronger regulations were
necessary.
In 1962, the FDA began its revisions to the 1941 regulations, which
incorporated the Recommended Daily Allowance (RDA), restricted
the maximum number of vitamins in supplements to 150% of that
given RDA 62 and required a disclaimer on supplements stating:
"[v]itamins and minerals are supplied in abundant amounts by the
foods we eat ... Except for persons with special medical needs, there
[was] no scientific basis for recommending routine use of dietary supplements." 63 Throughout the revision process, the FDA faced strong
opposition by many special interest groups, especially members of the
health food industry. These groups argued that "the FDA limited individuals' freedom of choice, and accused the agency of dictating laws
57. Id. at 916 ("A study of the three pamphlets reveals that the products therein described are
recommended for relieving stomach agonies, general weakness, anemia, premature old age, high
blood pressure, liver troubles, failing eyesight, sore feet; maintaining blood energy, muscular
activity, sound teeth and gums, healthy skin, hair and eyes, normal functioning of the pituitary
and thyroid glands, stomach, intestines, colon, liver and kidneys; and preventing arthritis and
stiff joints, excess weight, catarrh, nervous breakdown, steril-ity, and paralysis."); see also 21
U.S.C. § 321(k), (m) (2016).
58. Regulations for the Enforcement of the Federal Food, Drug, and Cosmetic Act, 6 Fed.
Reg. at 5,921-26.
59. Id.
60. w. Steven Pray, The FDA, Vitamins, and the Dietary Supplement Industry, U.S. PIJARMACIST (Oct. 17, 2008), https://www.uspharmacist.com/article/the-fda-vitamins-and-the-dietary-sup
plement-industry.
61. Id.
62. Any product with more than 150% of the RDA would be regulated as a drug and was
subject to higher FDA approval standards. Mark A. Kassel, From a History of Near Misses: The
Future of Dietary Supplement Regulation, 49 Fool & Diuo L.J. 237, 256 (1994); Regulations for
Enforcement of Federal Food, Drug, and Cosmetic Act, 31 Fed. Reg. 8,521, 8,522 (June 18,
1966).
63. Id. at 8,525.
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based on 'opinion-not facts.'"64 Therefore, while a majority of the
proposal was finalized in 1973, the FDA was forced to withdraw the
disclaimer from it.
After the FDA revisions were finalized, the health food industry
took to the courts to challenge the legality of the regulations. In National NutritionalFoods Association v. Food and Drug Administration,
the Second Circuit held the FDA could not classify and regulate dietary supplements as drugs due to their high vitamin and mineral potency. 65 In another case involving the National Nutritional Foods
Association, the Second Circuit held the FDA could not solely rely on
factors, such as the fear of possible toxicity and the belief that megadoses66 of vitamins were not nutritionally beneficial, to determine a
vendor's intent to market vitamins for therapeutic use. 67 Some members of the dietary supplement industry and the public believed the
federal government was grossly interfering with their right to product
choices as consumers. 68 These groups continued to lobby until Congress finally amended the Food, Drug and Cosmetic Act by passing
the Vitamin-Mineral Amendments of 1979, also known as the
Proxmire Amendments. 69
3.

The Proxmire Amendments

These amendments drastically limited the FDA's regulatory powers
over dietary supplements. Under these amendments, the FDA could
not restrict the maximum amounts of vitamins or minerals that could
be in a supplement, classify a substance as a drug based on potency
alone, or limit the combinations or amount of food ingredients. 70
Thus, these amendments essentially negated the FDA's regulatory
goal of protecting the public from mega-doses of vitamins and re64. Kassel, supra note 62, at 257 (citing CHARLES w. MARSHALL, VITAMINS AND MINERALS
HELP OR HARM? 15 (1985) (internal quotation marks omitted)).
65. 504 F.2d 761, 771, 789 (1974) (The Court invalidated § 125.1(h), which stated: "[a]ny product containing more than the upper limit of the U.S. RDA per serving (or where appropriate, per
daily recommended quantity) of a vitamin or mineral as specified in § 80.1(f)(1) of this chapter is
a drug ... ").
66. Kassel, supra note 62, at 237 ("[T]hree out of four Americans mistakenly believe that
megadoses of vitamins, minerals, or other dietary supplements will greatly improve their health
or increase their energy level. Therefore, Americans ingest dietary supplements in great excess
of that acquired in their daily food intake and of acceptable dietary levels, despite the want of
evidence linking increased doses with increased health benefits.").
67. Nat'l Nutritional Foods Ass'n v. Matthews, 557 F.2d 325, 335-36 (2d Cir. 1977).
68. Kassel, supra note 62, at 257.
69. See generally Federal Food, Drug, and Cosmetic Act Amendments, Pub. L. No. 94-278, 90
Stat. 410 (1976) (codified at 21 U.S.C. § 350 (1992 Supp.)); Kassel, supra note 62, at 258.
70. 21 U.S.C. § 350(a)(1); Kassel, supra note 62, at 258.
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turned the government to a laissez-faire approach to dietary supplement regulation. 71
Later that same year, the FDA attempted to reinstate its 1973 regulations by adapting them to conform to the newly adopted Proxmire
Amendments and the recent court decisions limiting the FDA's regulatory reach. 72 However, the National Products Association (previously referred to as National Nutritional Foods Association) once
again took their opposition to court and challenged the regulations on
procedural grounds. 73 The court reasoned that because the FDA did
not provide the public with an opportunity to comment on the
adapted regulations, they were improperly issued and ultimately

struck down. 74
The FDA did not give up, but made one final attempt to regulate
dietary supplements in its proposed Over-the-Counter (OTC) Monograph on Vitamins and Minerals Products of 1979.75 Unlike the previous regulations, which included restrictions based on the FDA's fear
of potential effects and beliefs about the necessity of certain substances, the Monograph contained extensive research on each of the
vitamins and minerals and concluded that based on the research,
eleven vitamins and three minerals could safely be marketed as dietary supplements. 7 6 However, the Monograph still purported that supplements intended to treat or prevent dietary deficient conditions
should be classified as drugs. 77
Ultimately, the National Products Association used its influence in
the industry and over the public to lobby against the regulations. At
the lobbyists' urging, Congress amended the Food, Drug, and Cosmetic Act a second time by preventing the drug classification based
solely on a product's intent to be used to treat or prevent a dietary
deficiency disease. 78 As a result, the FDA withdrew its Monograph
and returned to regulating the industry on an expensive and time-con-

suming case-by-case basis. 79
71. Kassel, supra note 62, at 258.
72. See generally Vitamin and Mineral Products: Labeling and Composition Regulations, 41
Fed. Reg. 45,977, 46,156-76 (Oct. 19, 1976).
73. Nat'l Nutritional Foods Ass'n v. Kennedy, 572 F.2d 377, 382 (2d Cir. 1978).
74. Id. at 383.
75. See generally Vitamin and Mineral Drug Products for Over-the-Counter Human Use, 44
Fed. Reg. 15,987, 16,126 (1979).
76. Id. at 16,141-42, 16174-75.
77. Id. at 16,131-32.
78. Voluntary Vitamins Act of 1981, S. 1362, 97th Cong., 1st Sess. (1981); Kassel, supra note
62, at 258.
79. Kassel, supra note 62, at 258.
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The Nutrition Labeling and Education Act of 1990 & The
Dietary Supplement Act of 1992

The Nutrition Labeling and Education Act (NLEA) was enacted in
1990.80 This Act was another amendment to the Food, Drug, and Cosmetic Act and established a new labeling standard for dietary supplements. 81 Section 343(r)(5)(D) provides in pertinent part that a "claim
made with respect to a dietary supplement of vitamins, minerals,
herbs, or other similar nutritional substances ... shall be subject to a
procedure and standard, respecting the validity of such claim, established by regulation of the Secretary." 8 2 The NLEA required the FDA
to implement procedural regulations to determine the validity of a
supplement's claim. 83 It also required validity studies for specific
claims including the relationship between vitamin B and neural tube
defects; antioxidant vitamins and cancer; zinc and immune functions;
and omega-3 fatty acids and heart disease.84
As had been the case in the past, the FDA's NLEA regulations
were met with significant opposition and lobbying efforts. As a result,
Senator Orrin Hatch sponsored the Health Freedom Act of 1992,

which would have annulled Section 343(r)(5)(D) of the NLEA by
prohibiting the "Secretary of Health and Human Services from establishing any requirement that such a claim or other information ... be
approved by or conform to a regulation issued by the Secretary before
the claim or information may be used." 8 5 Instead, if the Secretary asserts a supplement's claim violates the NLEA, the manufacturer may
seek a declaratory judgement in court. 86 While the Health Freedom
Act did not pass in either the House of Representatives or the Senate,

Congress did pass the Dietary Supplement Act of 1992 (DSA), which
delayed the FDA's labeling guidelines on dietary supplements until

the end of 1993.87
80. Nutrition Labeling and Education Act of 1990, Pub. L. No. 101-535, 104 Stat. 2353 (1990)
(codified at 21 U.S.C. §§ 343(q)-(r)).
81. Id.
82. Id. § 343(r)(5)(D).
83. Id.
84. Kassel, supra note 62, at 261.
85. Health Freedom Act of 1992, S. 2835, 102d Cong. (1992).
86. Id.
87. Prescription Drug User Fee Act of 1992, H.R. 5952, 102d Cong. (1992); Kassel, supra note
62, at 261 n.189 ("The bill, H.R. 6181, which included the Dietary Supplement Act of 1992
(DSA), passed through the House on October 5 and through the Senate on October 7, 1992.
Neither the House nor the Senate issued a report on the bill. The bill was signed into law on
October 29, 1992. The DSA was added to the Prescription Drug User Fee Act of 1992 (H.R.
6181) to pacify Senator warren Hatch, who has objected to the FDA's handling of dietary supplement regulation. During a Senate hearing on user fees, Senator Hatch told FDA Commis-
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DSHEA

During the year-long moratorium before the NLEA would take effect, Senator Hatch introduced a new bill, the Dietary Supplement
Health and Education Act of 1994 (DSHEA). 8 8 It was enacted to address the "debate concerning the importance of dietary supplements
in promoting health, the need for consumers to have access to current
and accurate information about supplements, and controversy over
the Food and Drug Administration's (FDA) regulatory approach to
this product category." 89 DSHEA, along with portions of the Food,
Drug, and Cosmetic Act, are the current controlling legislations for
dietary supplements.
The main provisions of DSHEA seem to further restrict the FDA's
regulatory power over supplements, while providing the agency with
additional tools to monitor the industry. DSHEA was the first to provide a specific definition for a dietary supplement. 90 Because supplement ingredients sold prior to October 15, 1994 were presumed to be
safe as they were already in the market, they did not require FDA
review and approval. 9 1 However, Section 413(a) of DSHEA considers:
A dietary supplement which contains a new dietary ingredient shall
be deemed adulterated under section 402(f) unless it meets one of
the following requirements: (1) The dietary supplement contains
only dietary ingredients which have been present in the food supply
as an article used for food in a form in which the food has not been
chemically altered[;] (2) There is a history of use or other evidence
of safety establishing that the dietary ingredient when used under
the conditions recommended or suggested in the labeling of the dietary supplement will reasonably be expected to be safe and, at
least 75 days before being introduced or delivered for introduction

into interstate commerce, the manufacturer or distributor of the dietary ingredient or dietary supplement provides the Secretary [of
Health and Human Services] with information, including any citation to published articles, which is the basis on which the manufacturer or distributor has concluded that a dietary supplement
containing such dietary ingredient will reasonably be expected to be
safe. 92

&

sioner Kessler that he was 'not very pleased' with the agency's regulation of the vitamin industry.
Senator Hatch has at least two vitamin manufacturers based in his state.").
88. Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 Stat.
4325 (1994) (codified as amended at 21 U.S.C. § 321(ff)(1)(A)-(E) (2016)).
89. ChapterI: Dietary Supplement Health And Education Act of 1994, U.S. DiFiP'r HEAI:[II
HUM.
SERVS. (Apr. 25, 2010 9:02 PM), http://www.mjota.org/images/ChapterI_DietarySupplem.. .pdf.
90. 21 U.S.C. § 321(ff)(1)-(3) (2020).
91. OFFICE OF DIErARY SUPPLEMENTS, supra note 11.

92. Dietary Supplement Health and Education Act of 1994 § 8; U.S. FOOD AND DRUG ADnote 2.

MINISTRATION, supra
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While this Section does provide some control over new ingredients
entering the market, a vast majority of supplement ingredients, such
as vitamins and minerals, were sold before the October 15, 1994 cutoff, and are therefore exempt from this provision. 93 Consequently, for
most supplements, the FDA cannot regulate them until after they
have entered the market and have negative effects on the consumer.
This places the burden on the FDA, rather than the manufacturer, to
prove a product is unsafe.
DSHEA also specified the labeling standards for dietary supplements. General information, such as the name of the product, the
word "supplement" or a statement indicating the product is a supplement, the net quantity of contents, the name and contact information
of the manufacturer or distributor, and directions for use, must be included on the label. 94 The label was also required to have a supplements facts panel that lists the serving size, servings per container, and
all dietary ingredients, with the amount per serving and the daily
value for each ingredient. 95 Other non-dietary ingredients such as artificial sweeteners, flavor, and fillers, must be listed in a separate ingredient section. 96 While manufacturers do not have to obtain FDA
approval or prove the effectiveness of their products, if they include
any structure/function claims on the label, they must also include a
97
disclaimer stating that the "FDA has not evaluated the claim."

DSHEA created the "Office of Dietary Supplements (ODS) within
the National Institutes of Health (NIH)." 9 8 According to Section 13 of
DSHEA, the two purposes of the ODS are: "(1) to explore more fully
the potential role of dietary supplements as a significant part of the
efforts of the United States to improve health care; and (2) to promote scientific study of the benefits of dietary supplements in maintaining health and preventing chronic disease and other health-related
93. See generally New book compiles list of pre-DSHEA dietary ingredients, NAT. PRODS. INSIDER (Nov. 7, 2017), https://www.naturalproductsinsider.com/ingredients/new-book-compileslist-pre-dshea-dietary-ingredients (referencing a book that lists over 1,850 "pre-DSHEA or old
dietary ingredients (ODIs) that were marketed and sold prior to October 15, 1994, the implementation date for the Dietary Supplement Health and Education Act (DSHEA) of 1994. These
dietary ingredients would be exempt from filing notifications with FDA as New Dietary Ingredients (NDIs).").
94. Dietary Supplement Health and Education Act of 1994 § 17(b).
95. Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling, U.S. FOOD & DRUG
ADMIN., https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-informa
tion/dietary-supplement-labeling-guide-chapter-iv-nutrition-labeling
(last updated Mar. 21,
2018); 21 C.F.R. 101.36(b) (2018).
96. U.S. FOOD AND DRUG ADMINISTRATION, supra note 95; 21 C.F.R. 101.4(g) (2016).
97. U.S. FOOD AND DRUG ADMINISTRATION, supra note 17.
98. Dietary Supplement Health and Education Act of 1994 § 13.
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conditions." 99 Thus, DSHEA gave the ODS the ability to conduct and
gather research regarding dietary supplements and their risk reducing
relationships with certain diseases, as well as provide expert advice to
the FDA and other agencies on issues involving dietary
supplements.100
While some provisions of the DSHEA seem to provide the FDA
with more regulating ability in the dietary supplement industry, the
Act as a whole has been criticized for providing manufacturers with
many loopholes to work around most of the regulations. In fact, since
its enactment, supplements experience less regulation than food additives, which must be proven safe before being introduced into the
market.1 0 1 Due to its weak regulations and sponsorship by Senator
Hatch-a politician with two supplement manufacturers in his statemany have also criticized the bill as favoring the multibillion-dollar
industry, rather than the average consumer.10 2
Ten years after the enactment of DSHEA, the U.S. Senate held a
hearing before the Oversight of Government Management, the Federal Workforce, and the District of Columbia Subcommittee of the
Committee on Governmental Affairs, regarding the effectiveness of
the FDA under the DSHEA.1 0 3 In his opening statement, Senator
Richard Durbin emphasized that the FDA's lack of action when it
comes to dietary supplements is largely due to the weak restrictions

provided by the DSHEA:
The law that was passed in 1994 was opposed by all public health,
medical, and professional nutrition groups, including the American
Cancer Society, the American Dietetic Association and all of the
major consumer groups in America, including the Consumer Federation of America . . . [M]eanwhile, consumers have been endangered by the FDA's inability to act on particular supplements, 155
people died after taking dietary supplements containing the stimulant ephedra, and thousands more suffered injury. Yet it took years,
literally years, for the FDA to ban this substance under this law,

DSHEA ...

Why did it take the FDA, the agency created by Presi-

dent Theodore Roosevelt to protect the American public from mys99. Id.
100. Id.
101. Determining the Regulatory Status of a Food Ingredient, U.S. Foo) & DRUG AMIN.,
https://www.fda.gov/food/food-ingredients-packaging/determining-regulatory-status-food-ingredi
ent (last updated Sept. 20, 2018).
102. See David Kessler, Cancer and Herbs, 342 New ENG. J. MED., 1742, 1742-43 (2000)
(Kessler was the commissioner of the FDA when DSHEA was passed.).
103. Dietary Supplement Safety Act: How is the Food and Drug Administration Doing 10
Years Later?: Hearing Before the Oversight of Gov't Mgmt., the Fed. Workforce, and the D.C.

Subcomm. of the Comm. on Governmental Affs., 108th Cong. 1 (2004) (opening statement of
Senator Voinovich).
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terious elixirs claiming to cure diseases, so long to finally pull the
plug on ephedra? The answer? DSHEA. The law has to be changed
to protect consumers. Millions of Americans take vitamins safely
every day, including this Senator and the Chairman . .. Until we
fundamentally change the law governing how supplements are regulated, agencies responsible for public health will constantly fall short
of monitoring the marketing practices of this industry. 104

Senator Durbin goes on to call out specific changes he would make to
"fix" DSHEA and ensure dietary supplements are safe:
I do not believe that every natural substance needs to be subject to
premarket safety testing. But at the very least, DSHEA should be
changed so that stimulants are tested before marketed . . . Another
change I would like to see made to DSHEA is making the adverse
event reporting system mandatory for serious adverse events . . . It
is absolutely necessary that we know when a product is seriously
harming people. How can the FDA effectively protect the public if
it does not know when the product is causing harm? Adverse event
reporting is not a cumbersome process compared to the premarket
safety and efficacy review prescription and over-the-counter drugs

go through. 105
In 2006, Congress did amend the DSHEA to require adverse event
reporting but has yet to impose any premarket approval requirements.
106

D.

FDA's Five Step Plan

Due to Congress' lack of action, on February 11, 2019, the FDA's
Commissioner Scott Gottlieb, M.D., issued a statement indicating the
FDA will take "new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA's oversight." 107 The statement first acknowledged the fact that the DSHEA had not been
updated for twenty-five years, while the supplement industry has expanded exponentially. 10 8 Commissioner Gottlieb goes on to explain
that in order to meet its public health responsibilities, the FDA must
reprioritize its oversight of dietary supplements, without overstepping
its regulatory role provided by Congress in the DSHEA. 109
The goal of this DSHEA modernization plan is to ensure the FDA
"achieve[s] the right balance between preserving consumers' access to
lawful supplements, while still upholding our solemn obligation to
104. Id. at 3-4.
105. Id.
106. See generally Dietary Supplement and Nonprescription Drug Consumer Protection Act,
Pub. L. No. 109-462, 120 Stat. 3469 (2006).
107. U.S. FOOD AND DRUG ADMINISTRATION, supra note 2.
108. Id.
109. Id.
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protect the public from unsafe and unlawful products, and holding accountable those actors who are unable or unwilling to comply with the
requirements of the law." 1 1 0 To accomplish this task, the FDA plans to
implement five steps.
The first step is to develop a new rapid-response tool in order to
communicate more effectively."' This would allow the FDA to simultaneously alert the public of dangerous ingredients and the manufacturer, so they know to hold production.1 1 2 Secondly, the FDA plans on
developing a regulatory framework that is flexible so it will evaluate
product safety, but continue to promote innovation. 1 3 As part of the
second step, the FDA will strengthen its policies around new dietary
ingredients (NDIs) by establishing "[a]n effective NDI notification
process [that] represents the FDA's only opportunity to evaluate the
safety of a new ingredient before it becomes available to consumers
and helps promote transparency and risk-based allocation of resources." 1 4 The third step will involve a collaboration with the Botanical Safety Consortium. 1 5 This will create a "public-private
partnership that will gather leading scientific minds from industry,
academia and government to promote scientific advances in evaluating the safety of botanical ingredients and mixtures in dietary supplements." 1 6 Fourth, the FDA will continue to take action against those
that pose a threat to public health.1 17 This will require stricter enforcement of NDI notification and labeling regulations." 8 To demonstrate,
the FDA simultaneously sent a total of seventeen warning and advisory letters to companies who were illegally selling "dietary supplements" that included new dietary ingredients not approved by the
FDA and marketing them as treatments to serious diseases, such as
Alzheimer's, diabetes, and cancer.1 9 The FDA also plans to increase
compliance and enforcement efforts against manufacturers who repeatedly do not follow good manufacturing and labeling practices.12 0
The final step will be to increase public communication to determine
if additional steps to further modernize DSHEA are necessary.121
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.

Id.
Id.
U.S.
Id.
Id.
Id.
Id.
U.S.

Id.
Id.
Id.
Id.

supra note 2.

FOOD

AND DRUG ADMINISTRATION,

FOOD

AND DRUG ADMINISTRATION, supra note 2.
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While this modernization plan has picked up some support from the
public, 2 2 it has been met with opposition from both the medical field
and the dietary supplement industry, albeit for different reasons. Although recognizing the need for more regulation on supplements, the
medical field believes the plan is not doing enough. 123 Members of the
dietary supplement industry, however, believe this plan is entirely unnecessary and that the DSHEA is sufficient as is.124

III.

ANALYSIS

Given that DSHEA was enacted more than twenty-five years ago,
the very purpose of the FDA's new plan was to modernize its previous
regulations under DSHEA in a way that would still allow supplements
to remain accessible to consumers, yet decrease the risks that have
emerged alongside increased supplement use. 125 Essentially, the FDA
wanted to close the policy gap between when DSHEA was enacted in
1994 and the current supplement society that has since developed.
This Analysis addresses whether the FDA's plan will successfully close
the policy gap while maintaining a balance between public safety and
supplement accessibility. First, this Part will consider the main policy

gaps left by DSHEA and discuss the likelihood that the FDA's plan
will address these issues. Then, this Part will compare the FDA's modernization plan with other international supplement regulations.

A.

Policy Gaps Left by the DSHEA

Since the DSHEA of 1994 was enacted as a response to -the heavy
lobbying from supplement manufacturers and supplement consumers,
122. Josh Long, FDA's willingness to explore reform of DSHEA draws mixed reactions, NAT.
(Feb. 13, 2019), https://www.naturalproductsinsider.com/regulatory/fda-s-willing
ness-explore-reform-dshea-draws-mixed-reactions ("Some consumer groups have argued reform
is sorely needed, including mandatory registration of dietary supplements products. Sandra Eskin, project director of food safety with The Pew Charitable Trusts, a global research and public
policy organization, commended Gottlieb for his plans to strengthen oversight of dietary supplements. 'Clearly, more must be done to ensure that unsafe products are not marketed,' she said in
an email. 'FDA needs to know what supplement products each company makes, as well as the
ingredients and copies of the product labels. This information is absolutely essential to effective
oversight."').
123. Jann Bellamy, FDA promises industry-friendly "modernization" of dietary supplement
regulation, Sci.-BASED MED. (Feb. 14, 2019), https://sciencebasedmedicine.org/fda-promises-in
dustry-friendly-modernization-of-dietary-supplement-regulation.
124. Long, supra note 122 ("Daniel Fabricant, Ph.D., leads the Natural Products Association
(NPA) and is a former FDA official who oversaw what was formerly known as the Division of
Dietary Supplement Programs. In a statement, Fabricant said dietary supplements are safe, and
he encouraged 'FDA to use the current tools it has at its disposal to protect consumers from
companies selling illegal products masquerading as nutritional supplements."').
125. U.S. FOOD AND DRUG ADMINISTRATION, supra note 2.
PRODS. INSIDER
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DSHEA by and large made it easier for manufacturers to market their
products and limited the FDA's ability to both regulate products
before they enter the market and remove products from the market. 126 As a general rule, the FDA may do so if that product is proven
unsafe and classified as adulterated. 127 According to the DSHEA, a
dietary supplement is considered adulterated if it "presents a significant or unreasonable risk of illness or injury under (i) conditions of
use recommended or suggested in labeling, or (2) . . . under ordinary
conditions of use[.]" 1 2 8 Prior to the DSHEA, supplements were regulated as food additives. As such, to prevent products from entering the
market or to remove products from the market, the FDA was only
required to show that the supplement was not "generally recognized
as safe." 129 Under the DSHEA, the FDA bears the burden of showing
that a supplement presents a significant or unreasonable risk by a preponderance of the evidence.1 30 Thus, by increasing the FDA's burden
of proof, Congress lowered the safety standard manufacturers must
meet in order to keep their products on the market. Multiple policy
gaps have arisen from the FDA's limited ability to classify supplements as adulterated. Unfortunately, a majority of these gaps will not
be filled by the FDA's new modernization plan.
1.

Recommended Dosages

To classify a supplement as adulterated, the FDA must show the
supplement is unsafe when taken at the manufacturer's recommended
dosage (or if no dosage is provided) at the dosage ordinarily taken.1 3 1
While the FDA may be able to show a supplement is harmful at some
dosages, if that dosage is higher than the recommended amount by
just one percent, there is essentially nothing the FDA can do to prevent that product from being marketed to consumers. This is significant because "U.S. consumers often do not follow recommended
dosages." 132 This is evidenced by a recent study indicating that fifteen
126. Richard E. Nowak, DSHEA 's Failure: Why a Proactive Approach to Dietary Supplement
Regulation Is Needed to Effectively Protect Consumers, 2010 U. Iui.. L. Rvv. 1045, 1055 (2010).
127. Id. at 1067.
128. 21 U.S.C. § 342(f)(1)(A) (2005).
129. Bruce A. Silverglade, Regulating Dietary Supplement Safety Under the Dietary Supplement Health and Education Act: Brave New World or Pyrrhic Victory?, 51 Foou & Diuc L.J.
319, 320 (1996) (citing 21 U.S.C. § 348).
130. 21 U.S.C. § 342(f)(1); Nutraceutical Corp. v. Von Eschenbach, 459 F.3d 1033, 1038 (10th
Cir. 2006).
131. 21 U.S.C. § 342(f)(1)(A).
132. Nowak, supra note 126, at 1069. Conducting a simple Google search for how much vitamins and minerals one should take yields a number of sources indicating that it is safe to take
more than the recommended amount. For example, when discussing how much of a supplement
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percent of people are taking more than the recommended daily dose
of over-the-counter drugs due to their belief that over-the-counter
drugs are safer than prescription drugs.1 33 Since people typically consider supplements to be even safer than over-the-counter drugs, 134 it is
likely that an even higher percentage of people take more than the
recommended dosages for supplements. Given that, like over-thecounter drugs, supplements can be extremely dangerous when taken
at high dosages, 135 the FDA should be given a greater ability to regulate supplements at dosages higher than the recommended amount.
Since the FDA does not have the ability to amend congressionally
prescribed limitations on its ability to regulate, the new modernization
plan does not include regulating supplements that are dangerous at
higher than recommended dosages. However, in Steps One and Four,
the FDA discusses increasing and improving communication with the
public regarding potential dangers of specific products. 136 This may
include additional warning requirements on labels to give consumers a
more complete narrative of the product and put them on notice of the
potential risks associated with taking higher doses of certain ingredients. 137 While this is a very cursory first Step and still does not prevent
supplements from entering the market, once consumers are made
aware of all the risks associated with supplements, they may be more

likely to lobby for legislation that gives the FDA more flexibility. 138
However, it is evident that this policy gap will not be filled by the
FDA alone: Congress must be the one to do so. Unfortunately, this is
not likely to occur without extensive lobbying, given the great weight
Congress gives to consumer accessibility.

is too much, webmd.com, a commonly referred to medical website, recommends looking at the
"tolerable upper intake level" and states that "[w]ith many vitamins and minerals, you can safely
take a dose much higher than the RDA or DV without coming close to the UL." Vitamins and
Minerals: How Much Should You Take?, WEBMD, https://www.webmd.com/vitamins-and-sup
plements/vitamins-minerals-how-much-should-you-take#1 (last visited Dec. 27, 2019).
133. Research: Many People Exceed Recommended Dose of NSAIDS, CLEVELAND CLINIC
(Apr. 10, 2018), https://newsroom.clevelandclinic.org/2018/04/10/research-many-people-exceedrecommended-dose-of-nsaids/.
134. See PRICE, supra note 8, at xii.
135. Nowak, supra note 126, at 1069. For example, taking high dosages of iron can increase
one's risk of cancer and heart disease, overdosing on Vitamin A can lead to liver damage and
bone loss, and excessive amount of Vitamin E can interfere with the blood's ability to clot. See
Andrew Weil, Can You Overdose on Vitamin and Mineral Supplements?, WEIL (Dec. 17, 2013),
https://www.drweil.com/vitamins-supplements-herbs/supplements-remedies/can-you-overdoseon-vitamin-and-mineral-supplements/.
136. U.S. Fool) AND DRUG ADMINISTRATION, supra note 2.
137. Id.
138. Dina ElBoghdady, FDA funding boosted through lobbying effort, WASH. POST (Nov. 30,
2011), https://www.washingtonpost.com/business/economy/fda-funding-boosted-through-lobby
ing-effort/2011/11/23/gIQAXHQ6COQstory.html.
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PremarketApproval

According to the legislative history of the DSHEA, "a dietary supplement, as with any food, is presumed to be safe. It therefore may be
lawfully marketed, unless and until the FDA, by a preponderance of
139
the evidence, shows that the supplement is 'injurious to health.'"
Therefore, most supplements are not subjected to a premarket approval process by the FDA. In fact, under DSHEA, if a supplement
does not contain a new dietary ingredient (NDI), it is "not subject to
any premarket notification requirements." 140 Conversely, if a supplement contains an NDI, the manufacturer must notify the FDA and
provide the FDA with information proving the safety and effectiveness of the supplement.1 4 1 After receiving notification of a manufacturer's use of an NDI, the FDA may require the manufacturer to
provide additional evidence and information to prove the safety of the
ingredient. 14 2 However, if the FDA does not respond to the notification within seventy-five days, the manufacturer may market the supplement and the burden of showing the supplement presents a
significant or unreasonable risk to consumers reverts to the FDA. 14 3
Given the drastic expansion of the supplemental industry and the vast
number of products entering the market, it is possible that the FDA is
not able to analyze each supplement containing an NDI within the
seventy-five day period. Therefore, the market could contain supplements with potentially dangerous ingredients.
Once again, given that DSHEA premarket notification and approval requirements only apply to supplements containing NDIs, the
FDA cannot shift the burden of proving supplement safety to manufacturers marketing products that do not contain an NDI. 144 While the
FDA's new modernization plan does not include premarket requirements for supplements not containing an NDI, Steps two through four
indicate the FDA will adopt stronger policies regarding NDIs, conduct
its own research on ingredient safety, and require stricter enforcement
of NDI notification requirements.1 45 In Step Two, the FDA recognizes
the NDI notification process is its only means of evaluating and regu139. S. Rr P. No. 103-410, at 21 (1994).
140. Nowak, supra note 126, at 1070; 21 C.F.R. § 190.6(a)-(f) (2016).
141. 21 C.F.R. § 190.6(a)-(f).
142. Id.
143. Id.
144. Nutraceutical Corp. v. Von Eschenbach, 459 F.3d 1033, 1039 (10th Cir. 2006) ("The burden remains on the [FDA] to show that risks associated with a dietary supplement outweigh
benefits and are, therefore, unreasonable.").
145. U.S. FooD AND DRUG ADMINISTRATION, supra note 2.
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lating supplements containing NDIs before they enter the market. 14 6
Though the plan does not specify how the FDA will strengthen these
policies, it is likely the FDA may heighten a manufacturer's burden of
proving the safety of its supplement and provide such evidence to the
public, given the FDA's focus on consumer safety and its goal to promote risk transparency.1 47 This will likely decrease the number of potentially dangerous supplements that enter the market as it will
require manufacturers to conduct more product safety studies to meet
their higher burden.
While implementing stronger NDI notification policies will help
protect consumer safety, these stronger policies will prove useless unless the FDA prioritizes responding to each manufacturer's NDI notifications, which proves challenging given the seventy-five-day time

limit provided by DSHEA.1 48 Therefore, Step Two will only be effective at lessening the policy gap left by DSHEA regarding premarket
approval if the FDA successfully implements Step Four. Step Four requires the FDA to enforce NDI notification requirements more
strictly.1 4 9 This will require the FDA to not only hold manufacturers
accountable, as they have done by sending a number of warning letters to manufacturers not complying with the current requirements, 5 0
but it will also require the FDA to hold itself accountable. To ensure
supplements containing NDIs are not entering the market simply because the seventy-five-day time limit expired, the FDA needs to ensure they are responding to NDI notifications in a timely manner.
Again, because the modernization plan is still in its beginning stages,
the FDA does not specify how it will ensure they are satisfying this
DSHEA requirement. 15 1
Step Three may be helpful in allowing the FDA to meet its Step
Four goals as it will allow the FDA and Botanical Safety Consortium
partnership to conduct its own research.1 52 By conducting its own
studies and gathering relatively unbiased research of NDIs by those
outside of the supplement industry, the FDA may be better equipped
at determining the validity of a manufacturer's safety research. This
will decrease the time the FDA must spend on each individual notification, which will allow them to process more within a shorter amount
of time. Additionally, the FDA is supposed to be unbiased because it
146. Id.
147. Id.
148. 21 C.F.R. § 190.6(a)-(f) (2016).
149. U.S. FOOD AND DRUG ADMINISTRATION, supra note 2.
150. Id.
151. Id.
152. Id.
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is not profiting from marketing the supplements themselves, which
means having it conduct its own research will ensure products entering the market are safe. Thus, while the FDA's new plan does not
necessarily close the policy gap created by DSHEA, it does lessen the
gap so long as each of the steps are effectively implemented. As indicated above, many of the steps interconnect and the FDA's failure to
implement any of the individual steps could result in a complete failure to achieve its goal of increasing consumer safety.
3.

Lack of Reporting

In 2006, Congress amended current supplement regulation in the
Dietary Supplement and Nonprescription Drug Consumer Protection
Act of 2006 which requires manufacturers to notify the FDA of any
reports of a serious adverse event they receive. 153 A serious adverse
event is defined as "any health-related event associated with the use
of a dietary supplement . . . that results in death; a life-threatening
experience; inpatient hospitalization; a persistent or significant disability or incapacity; or a congenital anomaly or birth defect."1 54 Most
negative effects do not rise to the level of a serious adverse event and
are therefore not subject to the reporting requirement.1 55 Additionally, this requirement does not apply to manufacturers unless the
event is reported to them.1 56 Should manufacturers only hear of the
event through an unofficial source, they are not required to report it
to the FDA. 157 Therefore, although Congress attempted to fix the reporting deficit created by DSHEA through the Dietary Supplement
and Nonprescription Drug Consumer Protection Act of 2006, this
Amendment has not been very effective given that most harmful effects do not fall under its purview and of the harmful effects that are
subject to this requirement, not all are reported to the manufacturer.
The FDA's modernization plan also does very little to address this
gap in consumer protection. Step One, to develop a new rapid-response tool to increase effective communication, may only be useful
once the adverse event is reported to the FDA. 158 However, if con-

sumers may use the new tool to communicate with manufacturers, this
first step may increase the number of serious adverse events that are
officially reported.
153.
154.
155.
156.
157.

21 U.S.C.S. § 379aa-l(b)(1) (2020).
Id. § 379aa-1(a)(1)-(2)(A)(v).
Nowak, supra note 126, at 1072.
Id.
Id.; 21 U.S.C.S. § 379aa-l(b)(1).

158. U.S. FOOD AND DRUG ADMINISTRATION,

supra note 2.
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Additionally, if consumers use the communication tool to report all
harmful effects, not just serious adverse events, the FDA may then be
able to publicize the harmful effects and warn other consumers of the
potential dangers. If consumers are made aware of the potential dangers, it is more likely that they will avoid purchasing and consuming
those specific supplements associated with those risks, which in turn
increases consumer safety. Since consumer safety is one of the main
priorities of the FDA, 159 this will allow them to satisfy their goal despite not filling the policy gap in manufacturer reporting. However,
one major obstacle to increasing consumer awareness is the fact that
the burden is placed on consumers to seek out the information. While
the FDA currently makes dangerous risks available to consumers on
the FDA website, 160 not many consumers conduct in-depth research
prior to buying a general supplement, such as a multivitamin. Therefore, while the FDA may be able to publicize those risks sooner rather
than later, unless the FDA also educates consumers on the need to
research each supplement or makes the information more accessible
to the everyday consumer, it is unlikely that Step One will drastically
increase consumer protection.
4.

Market Removal

The last gap left in the wake of the enactment of DSHEA arises
because even once a supplement or ingredient is proven unsafe or
classified as adulterated, it still takes many years for the FDA to completely remove the product from the market. For example, the herb
ephedra, which was used to treat symptoms of bronchial asthma,
colds, influenza, allergies, and induce weight loss, 161 was responsible
for 155 deaths and thousands of additional injuries. 162 Although the
FDA was aware of these harmful effects, it still took over ten years for
63
the FDA to implement an effective ban on the dangerous herb.1 This
is largely due to the DSHEA requirement that the FDA prove the
product is unsafe at the recommended dose. 16 4 Once the FDA banned
159. Id.
160. Recalls, Market Withdrawals, & Safety Alerts, U.S. FOOD & DRUG ADMIN., https://
www.fda.gov/safety/recalls-market-withdrawals-safety-alerts (last updated Jan. 16, 2021).
161. See Ephedra, NAT'L CTR. FOR COMPLEMENTARY

& INTEGRATIVE HEALTH, https://

www.nccih.nih.gov/health/ephedra (last updated July 2020); Ephedra, DRUGS.COM, https://
www.drugs.com/npp/ephedra.html (last updated Aug. 5, 2020).
162. Dietary Supplement Safety Act: How is the Food and Drug Administration Doing 10
Years Later?: Hearing Before the Oversight of Gov't Mgmt., the Fed. Workforce, and the D.C.
Subcomm. of the Comm. on Governmental Affs., 108th Cong. 2 (2004) (opening statement of
Senator Richard Durbin).
163. Id.
164. Id.
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ephedra at a specific dose, manufacturers would come out with supplements containing the product at a lower dose, which in turn would
require the FDA to conduct more studies in order to prove the new
dosage was still harmful. The FDA did not successfully completely ban
the substance until 2006 when the Tenth Circuit determined the FDA
satisfied its burden of proof by conducting a risk-benefit analysis and
showing the potential risks of the substance as a whole outweighed
any supplement benefit.1 65 This is just a single example demonstrating
the ineffectiveness of DSHEA at eliminating unsafe supplements
from the market until after the fact, when substantial damage has already taken place.
Unfortunately, since the FDA does not have the authority to implement premarket regulations, most of the FDA's modernization plan
addresses risks after the products have already entered the market.
Additionally, Step Three may be the only helpful step when it comes
to allowing the FDA to more easily remove harmful supplements as it
will enable the FDA to conduct its own research. Given that the FDA
does not restrict its partnership with the Botanical Safety Consortium
to researching NDIs only, 166 Step Three may help the FDA satisfy its
burden for proving certain supplements or ingredients pose an unreasonable risk. Additional research could yield evidence that certain
supplements, previously thought of as safe, are actually dangerous, or
alternatively, it could prove certain combinations of existing ingredients are unsafe. Therefore, while this research may not initially prevent supplements from entering the market, it may allow the FDA to
more easily remove products from the market by providing more concrete evidence of the significant risks associated with certain ingredients or ingredient combinations.
Overall, the FDA's new modernization plan does very little to close
the gap regarding public safety in a way that reflects the drastic increase in supplement consumption since the enactment of DSHEA in
165. Nutraceutical Corp. v. Von Eschenbach, 459 F.3d 1033, 1039 (10th Cir. 2006); Nowak,
supra note 126, at 1073-74 ("In Nutraceutical, a dietary supplement manufacturer challenged the
validity of the ephedra ban after it was promulgated in 2004. The manufacturer, which produced
a dietary supplement containing small amounts of ephedrine alkaloids, argued the ban was unlawful because the FDA could not demonstrate that dietary supplements containing less than 10
mg of ephedrine alkaloids qualified as adulterated. The district court granted summary judgment
for the manufacturer, holding that the FDA's use of a risk-benefit analysis was improper and
that the FDA had failed to meet its burden of showing that 10 mg dosages of ephedrine alkaloids
presented a significant or unreasonable risk of injury. After the district court ruling and while
the appeal was pending, the ban was effectively repealed. Eventually, fourteen months later, the
Tenth Circuit reversed the district court's decision and the ephedra ban was finally complete
after the Supreme Court refused to grant certiorari.").
166. U.S. FOOD AND DRUG ADMINISTRATION, supra note 2.
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1994, or its amendment in 2006. Each step of the plan continues to
favor consumer access over public safety, as it only allows the FDA to
address issues after they occur. Additionally, since the plan was announced nearly a year ago, the FDA has not stated more precisely the
regulations it plans to implement in order to carry out this plan. Thus,
supplements continue to simultaneously be increasingly consumed
and virtually unregulated. However, as this section discussed, many of
the gaps created by DSHEA cannot be closed by the FDA as Congress has limited the FDA's ability to do so. Therefore, an amendment
from Congress is likely the only way the United States will see a valid
balance between consumer access and public safety.
B.

FDA's Regulating Authority

While DSHEA places significant limitations on the FDA's ability to
regulate supplements, it is important to note that the FDA is not completely powerless when it comes to these products. Despite DSHEA
being an amendment to the Food, Drug, and Cosmetic Act of 1938,
much of the previous Act's provisions concerning food safety and prohibited acts remain in effect. Under the Food, Drug, and Cosmetic
Act, the FDA is the primary agency that administers and enforces the
Act. 167 To actualize Congress's intent, the FDA was given rulemaking
authority, labeling authority, general inspection authority, recall authority, and enforcement authority. 168
1.

Rulemaking Authority

One of the main ways the FDA administers and enforces the Act is
through rulemaking. The most used process by which the FDA implements regulations is called "notice and comment rulemaking." 169 During this process, the FDA first issues a proposed rule. 170 This proposal
includes not only regulation requirements, but also the FDA's intent,
as well as specific scientific and policy reasons for implementing the
rule. 171 The proposal also includes a request for public comments,
167. KATHRYN B. ARMSTRONG & JENNIFER A. STAMAN, CONG. RESEARCH SERv., R43609,
ENFORCEMENT OF THE FOOD, DRUG, AND COSMETIC ACT: SELECT LEGAL ISSUES 3 (2018); see

also 21 U.S.C. § 393(a) (2011).
168. 21 U.S.C. §§ 393(b)(1), 350(a)(1), 402.
169. FDA Rules and Regulations, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/regulato
ry-information/fda-rules-and-regulations (last updated June 1, 2020).
170. Dietary Supplement Safety Act: How is the Food and Drug Administration Doing 10
Years Later?: Hearing Before the Oversight of Gov't Mgmt., the Fed. Workforce, and the D.C.
Subcomm. of the Comm. on Governmental Affs., 108th Cong. 2 (2004) (opening statement of
Senator Durbin).
171. Id.
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which can be submitted on the Federal Government's electronic
docket website. 172
After reviewing the public comments, the FDA then decides
whether to abandon the proposed rule, issue a revised proposed rule,
or issue a final rule. 173 If the FDA issues a final rule, the regulatory
requirements, or codified portion, is published in the Federal Register
and under Title 21 of the Code of Federal Regulations. 174 The final
rule also responds to the comments and concerns relating to the rule
and explains the impact the rule will have on both the supplement
industry and supplement consumers. 175 The FDA often uses its
rulemaking authority to effectively carry out its other powers to administer and enforce the regulating Acts.

2.

Labeling Authority

The FDA also has the authority to regulate food labeling. This authority comes from two different acts and their amendments: The
Food, Drug, and Cosmetic Act of 1938 and the Fair Packaging and
Labeling Act.1 76 Under this authority, the FDA can dictate both what
manufacturers must include on their product labels and what they are
prohibited from including on these labels. 177 Manufacturers must include a number of sections on their product labels in order to be compliant under current FDA requirements. The required sections
include: a principal display panel, a statement listing the principal
place of business, an information panel, a nutrient panel, a statement
of identity, a statement identifying the net contents, a statement including any health claims, a statement including any structure function
claims, and, if the product falls under the definition of a dietary supplement under DSHEA, it must be labeled as such. 17 8 If any product
fails to adhere to any of these FDA requirements, those products will
be labeled as misbranded, which would allow the FDA to recall those
products and bring an enforcement action against the manufacturer in
a court of law. 179 This authority ensures that manufacturers are not
selling just anything under the guise of a dietary supplement. Further,
it allows the FDA to remove such products from the market and take
172. Id.
173. Id.
174. Id.
175. U.S. Fool) AND Dizuc ADMINISTRATION, supra note 169.
176. 21 C.F.R. § 1.23 (2019); Fair Packaging and Labeling Act, 15 U.S.C. § 1451.
177. Id.
178. 21 C.F.R. §§ 101.1, 101.2(a), 101.3(g), 101.5(a), 101.14(a)(1), 101.14(a)(5) (2020); see also
id. § 1.23 (2019); Fair Packaging and Labeling Act, 15 U.S.C. § 1451.
179. 21 U.S.C. §§?350(1), 402-03.
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action against any bad actors who carelessly or purposely mislabel
their products.
3.

General Inspection Authority

DSHEA requires supplements comply with current Good Manufacturing Practices ("GMPs") for contemporary food products and authorizes the FDA and the Secretary of Health and Human Services to
establish separate GMPs for dietary supplements.' 8 0 Since the passage

of DSHEA, the FDA has issued a final regulation regarding GMPs for
dietary supplements. 181 These regulations apply not only to manufacturers, but also to any company involved in packaging, labeling, and
storing supplements.18 2 Since the FDA has neither the time nor resources to check the quality of every product entering the market,
GMPs are crucial for ensuring product safety. Under this final regulation, "manufacturers are required to evaluate the identity, purity,
quality, strength, and composition of their dietary ingredients and dietary supplements."18 3
While GMPs are necessary until a better alternative is established,
it is important to highlight that the "very same company that stands to
profit from the sale of a given supplement is also responsible for evaluating the safety of and then accurately labeling the product[.]" 184 The
FDA is only responsible for addressing adulterated or misbranded
products once the products actually enter the market. 185 Thus, consumers should be cautious and ensure they are researching not only
the specific product, but whether any action has been taken against a
manufacturer in the past before consuming a supplement.
4.

Recall Authority

DSHEA provided the FDA with the authority to remove unsafe or
mislabeled products from the market. 186 Products are considered unsafe if they present an imminent hazard to public safety or pose a
180. 21 U.S.C. § 342(g) (2005).
181. See generally 21 C.F.R. § 111 (2007).
182. Id. § 111(1).
183. Federal GMPs for Dietary Supplements, NAT. PRODS. Ass'N, https://www.npanational.
org/regulatory/federal-gmps-dietary-supplements/ (last visited Nov. 3, 2020); 21 C.F.R. § 111.1(a)
(2007).
184. Becky Upham, FDA Sends Warning Letters to Several Supplements Claiming to Treat
Alzheimer's Disease and Other Serious Health Conditions, EVERYDAY HEALTH, everydayhealth.
com/diet-nutrition/fda-sends-warning-letters-several-supplements-claiming-treat-alzheimers-dis
ease-other-serious-heal/ (last updated Feb. 14, 2019).
185. Id.
186. 21 U.S.C. §?3501(b)(1)(A) (2011).
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significant or unreasonable risk of illness or injury. 187 Unsafe or misla-

beled products can be removed from the market by either a voluntary
recall or a mandatory recall. 188 Generally, unless a product poses an
immediate risk of illness or injury to the public, the FDA will notify
the manufacturer that its product is either unsafe or mislabeled and
give the manufacturer the opportunity to cease production and recall
its own products already on the market. 189 If the manufacturer or
other responsible party refuses to recall voluntarily and cease production and recall its products, the FDA can issue an order to the manufacturer and anyone involved in the distribution process to
immediately cease distribution and recall the product themselves.1 90
This is an essential power that enables the FDA to ensure consumers
are protected from unsafe or mislabeled products.
5.

Enforcement Authority

The Food, Drug, and Cosmetic Act and its amendments, including
DSHEA, are generally enforced using administrative mechanisms,
"including warning and untitled letters, import alerts, recalls, debarments, and civil money penalties." 19 1 However, the agency can also
bring enforcement actions against companies that manufacture or distribute adulterated or misbranded supplements.1 92
Because FDA, like most executive agencies, does not have independent litigating authority, it must coordinate with the Department of
Justice (DOJ) to pursue criminal or civil remedies . . . For serious
FD&C Act violations, the FDA, in coordination with DOJ, has a
wide range of civil and criminal remedies. For example, the FD&C
Act authorizes the government to sue violators of the Act in court
in order to punish or prevent future violations. Such civil actions
include imposing money penalties, injunctions, and seizures. Other
enforcement actions include warning letters, import alerts, recalls,
and debarments. For extremely serious violations, FDA and DOJ
may collaborate to bring criminal charges. A criminal violation of
the FD&C Act does not require that the perpetrator have a "guilty
mind." Intentional or repeated violations of the Act may result in
19 3
multiple years of imprisonment and significant criminal fines.

While the FDA typically sticks to using less severe enforcement actions, such as warning letters or voluntary recalls, the Supreme Court
U.S.C. § 342(a)(1) (2005).
U.S.C. § 3501(b)(I)(A).
§?3501(a).
U.S.C. §?3501(b)(1)(A).
ARMSTRONG & STAMAN, supra note 167, at 9.
21 U.S.C. §§ 342-43.
193. ARMSTRONG & STAMAN, supra note 167, at 1.
187.
188.
189.
190.
191.
192.

21
21
Id.
21
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has held that the FDA has broad discretion when it comes to enforcing the Food, Drug, and Cosmetic Act and its amendments. 194 Supreme Court precedent recognizes that the FDA enjoys significant
discretion over enforcement of most Food, Drug, and Cosmetic Act
provisions. Given the vast increase in supplemental use and production, it is time the FDA uses its more severe enforcement powers to
punish current violators and prevent future violations.

IV.

IMPACT

Although the FDA's modernization plan takes a crucial first step to
providing safer supplements to consumers, it is unlikely to yield any
meaningful change in this industry. Most of the five steps are too general and do not provide the consumer with any information as to how
the FDA will implement the steps or how they will provide further
protections to the everyday consumer. 195 For example, in Step Two,
the FDA states it will develop a new process "to foster the submission
of new dietary ingredient (NDI) notifications." 196 Given the fact that
the "NDI notification process represents the FDA's only opportunity
to evaluate the safety of a new ingredient before it becomes available
to consumers[,]" 197 this is arguably the most important step in the
FDA's modernization plan. However, the FDA has provided no new
information since announcing its plan regarding the steps it has taken
in developing a more effective NDI notification process, or whether it
has experienced any positive changes since announcing its commitment to modernizing the DSHEA.
By not developing specific or targeted steps, the FDA has actually
done itself a disservice. Although the FDA has committed itself to
more oversight of an exponentially growing industry, it has not provided any measurable goals to which it can look to in order to determine whether it is making any progress in achieving those goals. 198 In
addition, by not having specific goals, it will be harder for the FDA to
determine what smaller steps they will need to take in order to effectively modernize DSHEA overall. This may be why the FDA has not
made additional statements about its modernization progress since the
plan's announcement in February 2019.199
194. Heckler v. Chaney, 470 U.S. 821, 831 (1985).
195. U.S. FOOD AND DRUG ADMINISTRATION, supra nOte 2.
196. Id.
197. Id.
198. See generally Developing Measurable Goals and Objectives, CTR. FOR APPLIED RES.
Sois., http://www.ca-cpi.org/docs/Publications/Other/SPFTipSheet_03_MeasurableGoals.pdf
(last visited Feb. 3, 2020).
199. U.S. FoOD AND DRuG ADMINISTRATION, supra note 2.
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In addition to providing general statements of what the FDA hopes
to accomplish in the future, some of the steps in the FDA's new plan
simply reiterate what the FDA was already doing.200 In its fourth step,
for example, the FDA states:
[W]e'll continue to take actions to protect public health .. . We're
already making our internal processes more efficient for taking enforcement action when products claiming to be supplements contain
unlawful ingredients, including drug ingredients. For example, last
April we took strong action to protect consumers from the dangers
of dietary supplement products marketed in bulk and containing
1
pure and highly concentrated caffeine.2 0

Consumers may read this last step to mean that the FDA was not
adequately doing what it was supposed to be doing in the first place.
While improving existing processes will undoubtedly help protect consumers from potentially dangerous supplements, taking actions
against companies after their products have already entered the market does not necessarily modernize DSHEA, especially since the FDA
was already engaging in this type of regulatory behavior. 202 Therefore,
to achieve its goal of modernizing DSHEA, it is necessary for the
FDA to develop specific steps that have not previously been implemented by the agency.
There are multiple ways the FDA can increase regulation while adhering to the limitations prescribed in DSHEA and retaining a general balance between consumer access and public safety. There are
four specific policies the FDA can adopt to help meet its goal of modernizing DSHEA. First, the FDA should require an age recommendation of eighteen years or older be listed on the product's label and
packaging. Second, the FDA must implement a system that allows the
agency to conduct randomized checks to ensure harmful ingredients
are not allowed into the market. Third, the FDA should consider the
importance of conducting unbiased research. Lastly, requiring specific
warning labels on all supplements can aid in increasing consumer
awareness.
A.

Age Recommendations

Under its rulemaking and labeling authorities, the FDA should require product labels on supplements to contain the statement: This
product is not intended to be used by those under the age of eighteen.
Additionally, within the product's nutrient panel, the FDA should re200. McGinley, supra note 4.
201. U.S. FooD AND Dkua ADMINISTRATION, supra note 2.
202. Id.
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quire a warning that states the nutrient information is based on an
adult's diet. Finally, within the directions, the FDA should require
manufacturers to include the warning that the dose recommendations
are strictly for adults and that parents should consult a medical professional before administering to anyone under the age of eighteen.
Overall, there is a general consensus among the medical community
and consumers that children between the ages of four and twelve
should not take supplements unless they are experiencing a specific
deficiency or issue that can be safely treated with dietary supplements. 203 The dosage of vitamins and minerals in most general multivitamins contain roughly twice as much the recommended amount
children under twelve should digest.204 Many of these ingredients are
205
In
potentially poisonous to children when taken at high dosages.
fact, the FDA requires all supplements containing iron to include a
warning label stating, "[a]ccidental overdose or iron-containing products is a leading cause of fatal poisoning in children under 6."206 Although supplements can potentially be more harmful to young
children, those under twelve years of age are not generally going out
and purchasing supplements themselves. Additionally, parents are
more likely to discuss supplements with a pediatrician prior to incorporating them into their young child's diet. 207 Therefore, requiring age
recommendations to be printed on product labels is not likely to cut
down on the adverse events involving children, as most are the result

of an accidental overdose. 208
However, recommending products be used by adults over the age of
eighteen may help cut down on the harmful effects found in those
between the ages of thirteen and seventeen. Nearly 95% of teenagers
have access to a smartphone, many of whom admit to being "online
on a near-constant basis." 20 9 The popularity of social media arguably
203. Jay L. Hoecker, Should I give multivitamins to my preschooler?,MAYO CLINIC (Aug. 27,
2020), https://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/expert-answers/
multivitamins/faq-20058310.
204. Andrew weil, Should More Children Take Vitamins?, WEIL (Feb. 19, 2008), https://
www.drweil.com/health-wellness/health-centers/children/should-more-children-take-vitamins/
(last updated Nov. 13, 2014).
205. Id.
206. 21 C.F.R. § 310.518(a)(1) (2016).
207. Hoecker, supra note 203.
208. Poison Statistics: National Data 2016, POISON CONTROL (Dec. 29, 2019) https://
www.poison.org/poison-statistics-national-data-from-2016/. In 2016, 46,306 children under the
age of six were hospitalized for acute poisoning due to a vitamin overdose. Id.
209. Monica Anderson & JingJing Jiang, Teens, Social Media & Technology 2018, PEw RES.
CTR. (May 31, 2018), https://www.pewresearch.org/internet/2018/05/31/teens-social-media-tech
nology-2018/.

146

DEPAUL LAW REVIEW

[Vol. 70:115

started in 2004, when MySpace reached one million active users. 21 0

Since then, many other social media platforms have gained traction
and are visited by roughly 3.5 billion people worldwide. 211 This rise of
social media also cultivated the birth of social media influencers, 2 12
who are often able to use their popularity and influence to advertise
different products to their viewers. Of the eight main social media
platforms, teenagers are most likely to actively engage with YouTube
and Instagram. 21 3 Two of the most popular products advertised by influencers on YouTube and Instagram fall within the supplement category. For example, last year, James Charles, a prominent beauty
YouTuber with over 25.2 million subscribers whose average age is between thirteen and twenty-five, 214 advertised Sugar Bear Sleep Vitamins to his viewers. 215 Additionally, Kylie Jenner endorsed FitTea, an
herbal tea that is supposed to promote detox and weight loss, to her
210 million followers on Instagram. 2 1 6
This phenomenon is potentially dangerous to teenagers, as individuals are most susceptible to social influence between the ages of thirteen and seventeen. 217 Additionally, this age group is more likely to
take risks than any other age group. 218 Therefore, not only will they
be more likely to purchase products advertised to them by someone
they see as influential, they are also less likely to do any research
about whether those products are necessary for their health. Since
consumers and manufacturers within the supplement industry have
210. Esteban Ortiz-Ospina, The rise of social media, OUR WORILD IN DATA (Sept. 18, 2019),
https://ourworldindata.org/rise-of-social-media.
211. Id.
212. What is a social media influencer?, Pixr.uim (Dec. 29, 2019), https://www.pixlee.com/defini
tions/definition-social-media-influencer ("A Social Media Influencer is a user on social media
who has established credibility in a specific industry. A social media influencer has access to a
large audience and can persuade others by virtue of their authenticity and reach.").
213. Distributionof social media users by age and platform, STATriSTA (Nov. 17, 2014), https://
www.statista.com/statistics/274829/age-distribution-of-active-social-media-users-worldwide-byplatform/; Anderson & Jiang, supra note 209.
214. James Charles YouTube Stats & Analytics Dashboard, INFLUENCER, https:/
www.noxinfluencer.com/youtube/channel/UCucot-Zp4280wkyRm2I7v2Q (last visited Jan. 17,
2021).
215. See Hilary weaver, James Charles Posts What He Says Will Be The Last Video On The
Tati Westbrook Drama, ELLE (May 18, 2019), https://www.elle.com/culture/celebrities/a275
16265/james-charles-new-video-tati-westbrook-drama.
216. Kylie Jenner (@kyliejenner), INSTAGRAM (Apr. 28, 2016), https://www.instagram.com/p/
BEv4jEmHGqK/.
217. See Lisa J. Knoll et al., Age-related differences in social influence on risk perception depend on the direction of influence, 60 J. ADoi.iLSCENCE1 53, 57-61 (2017); Susceptibility to Peer
Influences (Psychosocial Development), NAT'I. Juv. DEFEIiNDER CTR., https://njdc.info/susceptibil
ity-to-peer-influences-psychosocial-development (last visited Jan. 2, 2020).
218. NATIONAL. JUVENILE DEFENDER CENTER, supra note 217.
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pushed for broad consumer access, these potentially harmful products
are easily acquired by a majority of teenagers, 219 especially those who
are employed. Therefore, requiring supplements to include a universal
age recommendation may push those purchasing the supplements, and
their parents, to conduct their own research into the ingredients to
determine the side effects the products may have on those under the
age of eighteen. While this will help eliminate some of the adverse
effects involving teens in this vulnerable age group, 220 consumer access would remain the same as these products would remain on the
market and those under eighteen would have the opportunity to incorporate supplements into his or her diet, hopefully with adult
supervision.
B.

Implement Randomized Checks

Another regulation the FDA can institute to help shift the balance
between consumer access and public safety towards the latter is to
implement randomized ingredient checks under its general inspection
authority. DSHEA provides "the FDA with the authority to promulgate good manufacturing practice (GMP) regulations for supplements.
The Act stipulates that any new GMP regulations must be modeled
after current food GMP regulations and go through the required
rulemaking process, allowing for public notice and comment." 22 1 Currently, there are third-party certifications manufacturers can obtain as
219. Sugar Bear vitamins, along with similar hair, skin, and nail vitamins, sleep aids, detox
teas, anti-aging vitamins, and digestion supplements, are available both online and at popular
drug stores, such as Ulta Beauty. See SUGARBEARHAIR, https://www.sugarbearhair.com (last
visited Feb. 12, 2020); ULTA BEAUTY, https://www.ulta.com/brand/love-wellness (last visited Feb.
12, 2020).
220. Brent A. Bauer, Is melatonin a helpful sleep aid - and what should I know about melatonin side effects?, MAYO CiNic (Nov. 13, 2020), https://www.mayoclinic.org/healthy-lifestyle/
adult-health/expert-answers/melatonin-side-effects/faq-20057874 (Melatonin, the active ingredient in most sleep vitamins including Sugar Bear, has been linked to headaches, dizziness, nausea,
and in certain cases feelings of depression, mild tremors, and abnormally low blood pressure.);
What You Need to Know About the Purported Benefits and Side Effects of Detox Teas,
HEALTHLINE (Jan. 9, 2019), https://www.healthline.com/health/detox-tea-side-effects#precau
tions (Many detox teas contain high levels of caffeine and laxatives, which have been found to
cause increased breathing rates, muscle spasms, and abnormal heart rhythms. Some teas even
include medications and other chemicals, such as the illegal chemical ephedra, to boost the consumers activity level. In some cases, consumers experienced serious adverse events, including
heart attacks, strokes, seizures, and death.).
221. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, supra note 89; see also 21 U.S.C
§ 342(g)(2) (2005); Sandy Almendarez, DSHEA turned supplement manufacturing from the 'wild
west' to sophistication - podcast, NAT. PRODS. INSIDER (June 19, 2019), https://www.naturalpro
ductsinsider.com/contract-manufacturing/dshea-turned-supplement-manufacturing-wid-west-sophistication-podcast.
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evidence that they are adhering to GMP requirements. 222 While manufacturers may be subject to ingredient analyses to obtain GMP certifications, manufacturers are not required to be certified and the FDA
does not inspect supplements before they are marketed to consumers. 22 3 Manufacturers are responsible for maintaining accurate ingredient lists and labels, ensuring their ingredients are safe, and
examining the content of their products to confirm it matches the ingredient list.224
Unfortunately, not all manufacturers successfully fulfill their duties.
On numerous occasions, the FDA has received reports that certain
supplements contain ingredients not listed on the ingredient panel.
For example, in a study conducted by the California Department of
Public Health, "researchers analyzed data from an FDA database on
dietary supplements tainted with pharmaceuticals that had been identified by the agency from 2007 to 2016."225 The researchers found that
during that time a total of 776 supplements contained at least one
drug ingredient with about twenty percent containing more than one
type of drug.2 26 The most common drug ingredients found were
sildenafil (the active ingredient in Viagra), sibutramine (a banned
weight-loss drug), and synthetic steroids. 227 While the FDA was aware
of these adulterated supplements, most of the products were never
recalled and remain on the market today. 228 Researchers were not
able to determine why the products were not recalled. 22 9 However,
they did note that although the FDA can send warning letters to manufacturers, visit and inspect a manufacturer's factory, and issue a
mandatory recall to get adulterated products off the market, they
"rarely employ[ ] such tools[.] [O]ut of the 146 companies involved in
the making of the tainted supplements, the FDA issued just seven
warning letters; and did not issue any mandatory recalls." 230 This was
222. Almendarez, supra note 221.
223. Questions and Answers on Dietary Supplements, U.S. Fooo & Dauo ADMIN., https://
www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements (last updated July 22, 2019).
224. Id.
225. Rachael Rettner, Hundreds of Dietary Supplements Are Tainted with PrescriptionDrugs,
S(i. AM. (Oct. 12, 2018), https://www.scientificamerican.com/article/hundreds-of-dietary-supple
ments-are-tainted-with-prescription-drugs.
226. Jenna Tucker et al., Unapproved PharmaceuticalIngredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings, 1 JAMA N1ErwoRK OPEN
1, 3 (2018). Pharmaceuticals are among the most dangerous contaminants as they can interfere
with many vital medications commonly taken by Americans. Id. at 8.
227. Rettner, supra note 225.
228. Id.
229. Id.
230. Id.
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just one study that focused specifically on drugs found in supplements;
however, supplements have also been found to contain many other
types of undeclared ingredients, including some infection-causing bacteria. 231 This issue will only continue to worsen as the supplement
market continues to grow and manufacturers, who are less concerned
with public safety and more interested with turning a profit as quickly
as possible, enter the industry.
One way the FDA can combat this issue is by conducting randomized ingredient checks. Obviously, the FDA oversees more than just
dietary supplements. Even if the FDA's sole responsibility was to
oversee supplements, given the vast amount of supplements entering
the market each year and the relatively limited resources available to
the FDA, the agency must first focus its attention on products that
have shown to present a danger to public health.2 32 However, undeclared ingredients can cause serious adverse events. If the FDA was
to implement randomized ingredient checks, the number of supplements capable of causing serious injury or illness will decrease.
To accomplish this regulatory task, each year the FDA could set a
number of randomized checks it believed it could reasonably accomplish. As part of the check, the FDA could analyze a sample (or partner with a third-party that could conduct the analysis) to ensure the
supplement's ingredient list matches exactly what is marketed to the
consumers. If the supplement is contaminated, the FDA could then
issue a public alert and begin the process of getting the product recalled if necessary. This would help ensure consumers are buying products with the actual ingredients they are intending to buy and decrease
the number of harmful effects caused by adverse drug interactions.
This regulation process would also hold manufacturers more accountable and ensure they are not cutting corners when it comes to ingredient quality and purity. Because this step will not require premarket
approval and many companies are not trying to market contaminated
products, this process will not discourage innovation within the industry or drastically increase product cost. Therefore, implementing randomized ingredient checks will not only increase public safety; it will
also protect consumer accessibility.
231. U.S. FOOD AND DRUG ADMINISTRATION, supra note 160. In 2019, the FDA issued a
number of alerts and recalls due to supplements containing undeclared and potentially harmful
ingredients such as fish, lead, Stenotrophomonas maltophilia, and Salmonella. Id.
232. U.S. FOOD AND DRUG ADMINISTRATION, supra note 223 (After addressing products that
pose a threat to the public's safety, "[e]nforcement priorities then go to products thought to be
unsafe or fraudulent or in violation of the law. The remaining funds are used for routine monitoring of products pulled from store shelves or collected during inspections of manufacturing
firms.").
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Conduct Unbiased Research

The next way the FDA can increase public safety, while still maintaining consumer access to supplements, would be to conduct its own

unbiased research. The vast majority of current research studies involving supplement safety are funded by either members of the supplement industry or members of the medical community. As expected,
studies conducted by those involved in the industry are typically prosupplement use, while research conducted by medical professionals
typically find supplements are generally not beneficial or that more
research is needed. 233 These competing viewpoints can be confusing to
consumers and have potentially dangerous outcomes due to the
spread of misinformation.
One example of such confusion and threat to public safety involves
supplements containing biotin. In 2017, and again in late 2019, the
FDA issued a warning to consumers and health care providers that
biotin can interfere with certain medical tests. 234 Specifically, biotin
has been linked to "causing a falsely low result for troponin ... "235
This is significant because troponin is an important biomarker medical
professionals use to diagnose heart attacks. 236 By falsely showing low
levels of troponin, biotin is essentially causing false negatives for heart
attacks. 237 This has serious implications, both for the medical person233. Compare Is There Really Any Benefit to Multivitamins?, JOHNs HOPKINS MvD., https://

www.hopkinsmedicine.org/health/wellness-and-prevention/is-there-really-any-benefit-to-mutivi
tamins (last visited Jan. 3, 2020) ("The researchers concluded that multivitamins don't reduce the
risk for heart disease, cancer, cognitive decline (such as memory loss and slowed-down thinking)
or an early death. They also noted that in prior studies, vitamin E and beta-carotene supplements appear to be harmful, especially at high doses."), and Do multivitamins make you healthier?, HARV. HEAI:II PULL. (Mar. 2014), https://www.health.harvard.edu/mens-health/domultivitamins-make-you-healthier (last updated Dec.16, 2019) ("[T]here is still limited evidence
that a daily cocktail of essential vitamins and minerals actually delivers what you expect. Most
studies find no benefit from multivitamins in protecting the brain or heart."), with Charles S.
Fuchs et al., The Influence of Folateand Multivitamin Use on the FamilialRisk of Colon Cancer
in Women, 11 CANCER EPIDEMIOLOGY, BJOMARKIRS & PREVENTION 227 (2002) (finding that
the risk of colon cancer can be reduced by taking a proper multivitamin), and Margaret L. Watkins et al., Multivitamin Use and Mortality in a Large Prospective Study, 152 AM. J. EPID.MIoLOGY 149 (2000) (explaining that in this study of over a million people, the death rate of those on
a multivitamin was significantly reduced), and Paul S. Aisen et al., A Pilot Study of Vitamins to
Lower Plasma Homocysteine Levels in Alzheimer Disease, 11 AM. J. GIRIATRIC PSYCIIIATRY
246 (2003) (noting that in particular, Vitamins C and E, when used in combination, have shown
great benefit for the reduction of the risk of Alzheimer's disease).
234. UPDA TE: The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication, U.S. FOOD & DRUG ADMIN. (Nov. 5, 2019), https://www.fda.gov/medical-devices/
safety-communications/update-fda-warns-biotin-may-interfere-lab-tests-fda-safety-communica
tion.
235. Id.
236. Id.
237. Id.

2020] SUPPLEMENTING DSHEA ONE STEP AT A TIME

151

nel trying to diagnose and treat patients and for patients themselves,
who may not be given the medical attention they require as a result of
this interference. Due to these warnings, the medical community has
strongly advised the public against taking supplements containing
biotin.238
Alternatively, biotin is a popular supplement and is heavily marketed to those searching for a vitamin to support one's outward
beauty. Biotin is the main active ingredient in most hair, skin, and nail
supplements, and is among the active ingredients in many multivitamins.2 39 While the National Institute of Health recommends the
average adult consume roughly thirty micrograms of biotin daily, 240
most supplements contain much higher dosages of the vitamin. 2 4 1
While there is no evidence that biotin is toxic to humans at high dosages, 242 its potential dangerous interactions are often downplayed by
the supplement industry.
Given that each industry is motivated by its own agenda, many consumers are not sure who they can trust when it comes to research
about a supplement or ingredient. Therefore, it is important that the
FDA conduct its own research to determine the validity of claims
made by both the medical and supplement industries. While the third
step of the FDA's modernization plan indicates it plans to partner
with the Botanical Safety Consortium to evaluate "the safety of botanical ingredients and mixtures in dietary supplements," 243 this partnership is limited to researching botanical ingredients. As evidenced
above, there are other ingredients such as vitamins and herbs, that
should also be studied by an unbiased institution to help prevent potential threats to public safety and decrease the amount of contradictory information that can confuse consumers. Since the FDA has
stated its intent to partner with one third party, it is reasonable to
suggest the FDA partner with other third parties who may have additional resources to conduct such studies. With the exponential growth
in the supplemental industry, the once arguably balanced relationship
between consumer access and public safety established by DSHEA
238. Diana K. wells, What Are the Side Effects of Biotin?, HEALTHLINE, https://www.health
line.com/health/biotin-side-effects (last updated Oct. 1, 2019).
239. Biotin Fact Sheet for Consumers, OFF. DIETARY SUPPLEMENTS, NAT'L INSTS. HEALTH,
https://ods.od.nih.gov/pdf/factsheets/Biotin-Consumer.pdf (last updated Dec. 8, 2017).
240. Id.
241. Korin Miller, The Truth About Biotin Supplements, According to Nutritionists, YAHOo!
LIFE (May 18, 2018), https://www.yahoo.com/lifestyle/truth-biotin-supplements-according-nutri
tionists-120000465.html ("[M]any supplements contain[ ] anywhere from 1,000 to 10,000 micrograms of biotin per pill.").
242. OFFICE OF DIETARY SUPPLEMENTS, supra note 239.
243. U.S. FOOD AND DRUG ADMINISTRATION, supra note 2.
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has shifted to favor consumer access. By conducting unbiased research
studies, the FDA will take a step in rebalancing this important rela-

tionship and achieving its goal of modernizing DSHEA.
D.

Increase Warning Labels

The final regulation the FDA can implement is using its labeling
and rulemaking authorities to increase public safety by requiring
stricter warning labels on all supplements. Current FDA regulations
require five statements be included on the label of a dietary supplement: "(1) the statement of identity (name of the dietary supplement);
(2) the net quantity of contents statement (amount of the dietary sup-

plement); (3) the nutrition labeling; (4) the ingredient list; and (5) the
name and place of business of the manufacturer, packer, or distributor." 2 " Furthermore, by law, only supplements making structure and
function claims are required to label their products as: "This statement has not been evaluated by the FDA. This product is not intended
to diagnose, treat, cure, or prevent any disease." 24 5 Therefore, so long
as a manufacturer is simply listing the supplement as containing a specific ingredient, such as "vitamin C supplement," or describing a correlation between the supplement and risk reduction in a disease or
condition, that manufacturer is not required to include this disclaimer

on the label.
Given that a majority of supplements promote some type of health
benefit, most consumers believe these products are regulated by the
FDA.2 " While many supplements are labeled with the disclaimer that
the product is not evaluated by the FDA, requiring all supplements to
display a label with this disclaimer will help ensure consumers are informed of this issue. Additionally, of the supplements that are cur244. Dietary Supplement Labeling Guide: Chapter I. General Dietary Supplement Labeling,
U.S. FooD & DRUG ADMIN., https://www.fda.gov/food/dietary-supplements-guidance-docu
ments-regulatory-information/dietary-supplement-labeling-guide-chapter-i-general-dietary-sup
plement-labeling (last updated Mar. 21, 2018); 21 C.F.R. § 101.3(a) (2020); 21 C.F.R. § 101.7
(2016); 21 C.F.R. § 101.105(a) (2020); 21 C.F.R. § 101.36 (2018); 21 C.F.R. § 101.4(a)(1) (2016);
21 C.F.R. § 101.5 (2020).
245. 21 C.F.R. § 101.93(b)-(c) (2016); 21 U.S.C. § 343(r)(6); see also U.S. FOOD AND DRUG
ADMINISTRATION, supra note 223 (Manufacturers are "responsible for ensuring the accuracy and
truthfulness of [structure and function] claims; they are not approved by FDA. For this reason,
the law says that if a dietary supplement label includes such a claim, it must state in a 'disclaimer'
that FDA has not evaluated this claim. The disclaimer must also state that this product is not
intended to 'diagnose, treat, cure or prevent any disease,' because only a drug can legally make
such a claim.").
246. Geoffrey Kabat, Natural Does Not Mean Safe: Herbal supplements are unregulated,
overhyped, and potentially deadly, SLAE (Nov. 26, 2012, 3:36 PM), https://slate.com/technology/
2012/11/herbal-supplement-dangers-fda-does-not-regulate-supplements-and-they-can-bedeadly.html.
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rently required to contain the disclaimer, many manufacturers place
the disclaimer along the side of the bottle, perpendicular to all other
text on the label. This draws very little attention to the disclaimer, and
it is less likely to be read by the consumer. The FDA can require the
disclaimer to appear in bold, attention-grabbing font, right above the
supplement facts to help increase the likelihood that the consumer
purchasing the product will read it beforehand.
If consumers are made aware that supplements are not evaluated by
the FDA, they will be more likely to do their own research about supplements and discuss any potential side effects with their doctor. This,
in turn, will help consumers purchase only the specific supplements
needed to combat a deficiency or needed to treat a specific condition.
Therefore, with individuals consuming a more narrowly tailored
amount of supplements, they will be less likely to experience the
harmful effects associated with combining different supplements together, along with other medications they may also be taking. Thus,
requiring more warning labels will promote public safety.
Conversely, it is important to note that if people are consuming
fewer supplements, the overall demand for supplements will decrease.
The decrease in demand combined with an increase in regulation may
247
result in a decrease in supply and, ultimately, an increase in price.
As the price for a product continues to increase, the public's accessibility begins to decline. Therefore, as people consume fewer supplements, especially general supplements such as a multivitamin, public
access to supplements overall will decrease. However, given that many
supplements already contain the disclaimer, it is likely that increasing
these warnings will only affect a small niche of consumers who were
previously unaware. Similarly, because manufacturers are already required contain a disclaimer on their products, requiring a more visible
disclaimer will not likely have a significant impact on supply. Therefore, implementing this regulation change will likely maintain the balance between public safety and consumer access.
Overall, it is necessary for the FDA to implement new, specific
steps to combat the "bad actors" attracted to this billion-dollar industry.248 While most supplement products do not pose a substantial risk
to one's physical health, many products make false claims and contain
247. Dustin Chambers & Courtney A. Collins, How Do Federal Regulations Affect Consumer
Prices?An Analysis of the Regressive Effects of Regulation, MERCATUS CENTER GEO. MASON U.
(Feb. 23, 2016), https://www.mercatus.org/publications/regulation/how-do-federal-regulations-af
fect-consumer-prices-analysis-regressive; see also Editors of Encyclopedia Britannica, Supply
and demand, ENCYCLOPEDIA

mand (last visited Jan. 4, 2020).
248. McGinley, supra note 4.

BRITANNICA,

https://www.britannica.com/topic/supply-and-de
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"filler" ingredients 249 that simply are not worth the consumer's
money. By implementing stronger regulations, it is possible that the
approval process will become more costly and time-consuming for
manufacturers, which in turn could increase market price for supplements. 25 0 Therefore, stronger regulations could have a disproportionately negative effect on those with a lower socio-economic status.
However, such regulations will help ensure the safety and efficacy of
the products that do enter the market, which will prove more beneficial to consumers in the long run. Given that other countries also look
to American legislation for guidance on how to regulate this industry
in their own countries, 2 51 it is likely that stronger restrictions will not
only benefit American consumers, but consumers all over the world.

V.

CONCLUSION

As the number of Americans who consume multiple dietary supplements on a daily basis continues to increase, the need for stronger
regulations over these products becomes more evident. By preventing
the FDA from implementing a pre-market approval process, DSHEA
has inhibited the agency's ability to protect the public from potentially
dangerous products and bad actors looking to get rich quick from this

profitable industry. While the FDA has begun the process of implementing stricter regulations to prevent these adverse events from taking place, the outcome of these efforts will likely fall short without
legislative reform. 25 2
249. Julie Dennis, Dietary Supplement Excipients, Fillers and Binders: What's Hot and What's
Not?, wiioiis Foons MAC. (June 7, 2016), https://wholefoodsmagazine.com/blog/dietary-supple
ment-excipients-fillers-and-binders-whats-hot-and-whats-not/.
250. wendan wang, InternationalRegulations on Dietary Supplements: Challenges and Opportunities, BuRDOCK GRP. (Apr. 1, 2016), http://burdockgroup.com/international-regulations-ondietary-supplements-challenges-and-opportunities/. Lengthy and expensive approval processes
lead to a sharp decline in the amount of products entering the market in Japan prior to less
restrictive regulations being adopted in 2015. Id.
251. Most foreign legislation involving dietary supplements includes definitions and requirements from DSHEA. See generally Heizo Tanaka et al., Current System for Regulation of Health
Foods in Japan,47 JAPAN Mesa. ASS'N J. 436, 437 (2004); About Natural Health Product Regulation in Canada, Gov'T CAN., https://www.canada.ca/en/health-canada/services/drugs-healthproducts/natural-non-prescription/regulation.html (last modified Aug. 11, 2016); Food supplements, EUR. Foon SAFiYrv Atrr., https://www.efsa.europa.eu/en/topics/topic/food-supplements
(last visited Mar. 12, 2020).
252. McGinley, supra note 4 ("The Center for Science in the Public Interest said that while it
welcomed the enforcement action, it wanted more done. 'The FDA is hampered by a terrible law
and drastically limited resources within that there's only so much you can do,' said Peter Lurie, a
former FDA official who is president of the nonprofit.").
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Most steps in the FDA's new modernization plan are too general
and often incorporate actions the FDA is already authorized to do. 2 53
Thus, it is unlikely that they will yield significant changes in how the
supplement industry operates. The FDA's five step plan essentially
provides that the FDA will implement these steps without specifying
how it plans to do so. Most importantly, the FDA's plan fails to stipulate how the Steps will provide further protections to the everyday
consumer. Therefore, it is essential for the FDA to adopt more spe-

cific policy changes.
By requiring age recommendations on labels, implementing randomized ingredient checks, conducting additional unbiased research,
and increasing warning labels, the FDA will stand a better chance at
successfully increasing public safety. Each of these specific policy
changes fall within the authority of the FDA and work to make different aspects of the industry safer for consumers. Given that three out
of four adults take at least one supplement daily 2 54 and the value of
the supplement industry is predicted to double in just six years, 255 it is
essential that the FDA effectively regulate this industry. Otherwise,
the potentially dangerous effects associated with using unauthorized
ingredients, having access to limited unbiased information, and uninformed consumers will continue to get worse.
Aarika Nieto

253. Id. ("Pieter Cohen, an associate professor of medicine at Harvard Medical School, said,
'The FDA seems to be restating things they have been doing for years. Not making any changes.
There is nothing short of here except for a big PR push."').
254. New Data Reaffirm Trust and Confidence in Industry, Reveal Modern Trends and Habits
of American Consumers, COUNCIL FOR RESPONSIBLE NUTRITION (Oct. 18, 2018), https://www.
crnusa.org/newsroom/new-data-reaffirm-trust-and-confidence-industry-reveal-modern-trendsand-habits-american.
255. REPORTS AND DATA, supra note 1.
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